成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Sitagliptin Impurity 10

Sitagliptin Impurity 10 Struktur
1253056-01-7
CAS-Nr.
1253056-01-7
Englisch Name:
Sitagliptin Impurity 10
Synonyma:
Sitagliptin-8;Sitagliptin Impurity;3-Hydroxy Sitagliptin;Sitagliptin Impurity 09;Sitagliptin phosphate impurity 6;Sitagliptin Hydroxy Amide Impurity;1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluo;1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone;1-Butanone, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-;3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
CBNumber:
CB63360062
Summenformel:
C16H14F6N4O2
Molgewicht:
408.3
MOL-Datei:
1253056-01-7.mol

Sitagliptin Impurity 10 Eigenschaften

Siedepunkt:
542.2±60.0 °C(Predicted)
Dichte
1.61±0.1 g/cm3(Predicted)
storage temp. 
-10 to -25°C
L?slichkeit
Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
13.69±0.20(Predicted)
Farbe
White to Off-White

Sicherheit

Sitagliptin Impurity 10 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone is an intermediate in the synthesis of 3-Desamino-2,3-dehydro Sitagliptin (D281985), which is an impurity of Sitagliptin (S491000); a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.

Sitagliptin Impurity 10 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Sitagliptin Impurity 10 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 44)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14332 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3148 58
sgtlifesciences pvt ltd 		+8617013299288
 dj@sgtlifesciences.com China 12373 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
Moxin Chemicals 		+8617320513646
 mike@molcoo.com China 9563 58
Shanghai Payne Pharmaceutical Technology Co.Ltd 		021-58123769 18678586262
 info@paynepharm.com China 1354 58
QUALITY CONTROL SOLUTIONS LTD. 		0755-66853366; 13670046396
 ORDERS@QCSRM.COM China 24342 58
Daicel Chiral Technologies (China)CO.,LTD 021-50460086-9 15921403865
 han_yajun@dctc.daicel.com China 6791 65
BOC Sciences 1-631-485-4226; 16314854226
 info@bocsci.com United States 14055 65
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
 sales@bjcomparison.com China 4717 58

1253056-01-7()Verwandte Suche:

  • Sitagliptin-8
  • Sitagliptin Hydroxy Amide Impurity
  • Sitagliptin impurity 41/Sitagliptin Hydroxy Amide Impurity/3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
  • 3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
  • 1-Butanone, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-
  • (R/S)-3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
  • 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluo
  • Sitagliptin phosphate impurity 6
  • Sitagliptin Impurity 09
  • 3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one? (Sitagliptin Impurity）
  • 3-Hydroxy Sitagliptin
  • 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone
  • Sitagliptin Impurity
  • 1253056-01-7
Copyright 2019 ? ChemicalBook. All rights reserved